Global Over the Counter (OTC) Drugs and Dietary Supplements Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.

    Over the Counter (OTC) Drugs and Dietary Supplements market report explains the definition, types, applications, major countries, and major players of the Over the Counter (OTC) Drugs and Dietary Supplements market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Gilead Sciences

    • Johnson & Johnson

    • GlaxoSmithKline plc

    • Pfizer Inc

    • Alcon Inc

    • Sanofi SA

    • Reckitt Benckiser Plc

    • Allergan, Plc

    • Alliance Healthcare

    • Bausch & Lomb

    • Alacer Corp

    • Alfresa Pharma Corporation

    • Bayer Healthcare AG

    • AbbVie Inc

    • AstraZeneca plc

    • Novartis International AG

    • Alkalon A/S

    • The Colgate-Palmolive Company

    • Roche Holding AG

    • Merck & Co, Inc

    By Type:

    • by Category

    • Vitamin and Dietary Supplements

    • Cough & Cold Products

    • Analgesics

    • Gastrointestinal Products

    • Sleep Aids

    • Otic Products

    • Wart Removers

    • Mouth Care Products

    • Ophthalmic Products

    • Other

    • by Dosage Form

    • Tablets

    • Hard Capsules

    • Powders

    • Ointments

    • Soft Capsules

    • Liquids

    • Others

    • by Product

    • Branded

    • Generic Drugs

    By End-User:

    • Pharmacies

    • Grocery Stores

    • Vitamin

    • Health Food Stores

    • Online Pharmacies

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Over the Counter (OTC) Drugs and Dietary Supplements Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Over the Counter (OTC) Drugs and Dietary Supplements Outlook to 2028- Original Forecasts

    • 2.2 Over the Counter (OTC) Drugs and Dietary Supplements Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Over the Counter (OTC) Drugs and Dietary Supplements Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Over the Counter (OTC) Drugs and Dietary Supplements Market- Recent Developments

    • 6.1 Over the Counter (OTC) Drugs and Dietary Supplements Market News and Developments

    • 6.2 Over the Counter (OTC) Drugs and Dietary Supplements Market Deals Landscape

    7 Over the Counter (OTC) Drugs and Dietary Supplements Raw Materials and Cost Structure Analysis

    • 7.1 Over the Counter (OTC) Drugs and Dietary Supplements Key Raw Materials

    • 7.2 Over the Counter (OTC) Drugs and Dietary Supplements Price Trend of Key Raw Materials

    • 7.3 Over the Counter (OTC) Drugs and Dietary Supplements Key Suppliers of Raw Materials

    • 7.4 Over the Counter (OTC) Drugs and Dietary Supplements Market Concentration Rate of Raw Materials

    • 7.5 Over the Counter (OTC) Drugs and Dietary Supplements Cost Structure Analysis

      • 7.5.1 Over the Counter (OTC) Drugs and Dietary Supplements Raw Materials Analysis

      • 7.5.2 Over the Counter (OTC) Drugs and Dietary Supplements Labor Cost Analysis

      • 7.5.3 Over the Counter (OTC) Drugs and Dietary Supplements Manufacturing Expenses Analysis

    8 Global Over the Counter (OTC) Drugs and Dietary Supplements Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Over the Counter (OTC) Drugs and Dietary Supplements Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Over the Counter (OTC) Drugs and Dietary Supplements Export by Region (Top 10 Countries) (2017-2028)

    9 Global Over the Counter (OTC) Drugs and Dietary Supplements Market Outlook by Types and Applications to 2022

    • 9.1 Global Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global by Category Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Vitamin and Dietary Supplements Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Cough & Cold Products Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Analgesics Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Gastrointestinal Products Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Sleep Aids Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Otic Products Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Wart Removers Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Mouth Care Products Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global Ophthalmic Products Consumption and Growth Rate (2017-2022)

      • 9.1.11 Global Other Consumption and Growth Rate (2017-2022)

      • 9.1.12 Global by Dosage Form Consumption and Growth Rate (2017-2022)

      • 9.1.13 Global Tablets Consumption and Growth Rate (2017-2022)

      • 9.1.14 Global Hard Capsules Consumption and Growth Rate (2017-2022)

      • 9.1.15 Global Powders Consumption and Growth Rate (2017-2022)

      • 9.1.16 Global Ointments Consumption and Growth Rate (2017-2022)

      • 9.1.17 Global Soft Capsules Consumption and Growth Rate (2017-2022)

      • 9.1.18 Global Liquids Consumption and Growth Rate (2017-2022)

      • 9.1.19 Global Others Consumption and Growth Rate (2017-2022)

      • 9.1.20 Global by Product Consumption and Growth Rate (2017-2022)

      • 9.1.21 Global Branded Consumption and Growth Rate (2017-2022)

      • 9.1.22 Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Grocery Stores Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Vitamin Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Health Food Stores Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Over the Counter (OTC) Drugs and Dietary Supplements Market Analysis and Outlook till 2022

    • 10.1 Global Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.2.2 Canada Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.2.3 Mexico Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.2 UK Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.3 Spain Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.4 Belgium Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.5 France Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.6 Italy Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.7 Denmark Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.8 Finland Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.9 Norway Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.10 Sweden Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.11 Poland Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.12 Russia Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.3.13 Turkey Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.4.2 Japan Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.4.3 India Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.4.4 South Korea Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.4.5 Pakistan Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.4.6 Bangladesh Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.4.7 Indonesia Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.4.8 Thailand Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.4.9 Singapore Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.4.10 Malaysia Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.4.11 Philippines Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.4.12 Vietnam Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.5.2 Colombia Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.5.3 Chile Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.5.4 Argentina Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.5.5 Venezuela Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.5.6 Peru Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.5.7 Puerto Rico Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.5.8 Ecuador Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.6.2 Kuwait Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.6.3 Oman Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.6.4 Qatar Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.7.2 South Africa Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.7.3 Egypt Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.7.4 Algeria Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

      • 10.8.2 New Zealand Over the Counter (OTC) Drugs and Dietary Supplements Consumption (2017-2022)

    11 Global Over the Counter (OTC) Drugs and Dietary Supplements Competitive Analysis

    • 11.1 Gilead Sciences

      • 11.1.1 Gilead Sciences Company Details

      • 11.1.2 Gilead Sciences Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Gilead Sciences Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.1.4 Gilead Sciences Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Johnson & Johnson

      • 11.2.1 Johnson & Johnson Company Details

      • 11.2.2 Johnson & Johnson Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Johnson & Johnson Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.2.4 Johnson & Johnson Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 GlaxoSmithKline plc

      • 11.3.1 GlaxoSmithKline plc Company Details

      • 11.3.2 GlaxoSmithKline plc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 GlaxoSmithKline plc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.3.4 GlaxoSmithKline plc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Pfizer Inc

      • 11.4.1 Pfizer Inc Company Details

      • 11.4.2 Pfizer Inc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Pfizer Inc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.4.4 Pfizer Inc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Alcon Inc

      • 11.5.1 Alcon Inc Company Details

      • 11.5.2 Alcon Inc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Alcon Inc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.5.4 Alcon Inc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Sanofi SA

      • 11.6.1 Sanofi SA Company Details

      • 11.6.2 Sanofi SA Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Sanofi SA Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.6.4 Sanofi SA Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Reckitt Benckiser Plc

      • 11.7.1 Reckitt Benckiser Plc Company Details

      • 11.7.2 Reckitt Benckiser Plc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Reckitt Benckiser Plc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.7.4 Reckitt Benckiser Plc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Allergan, Plc

      • 11.8.1 Allergan, Plc Company Details

      • 11.8.2 Allergan, Plc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Allergan, Plc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.8.4 Allergan, Plc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Alliance Healthcare

      • 11.9.1 Alliance Healthcare Company Details

      • 11.9.2 Alliance Healthcare Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Alliance Healthcare Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.9.4 Alliance Healthcare Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Bausch & Lomb

      • 11.10.1 Bausch & Lomb Company Details

      • 11.10.2 Bausch & Lomb Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Bausch & Lomb Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.10.4 Bausch & Lomb Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Alacer Corp

      • 11.11.1 Alacer Corp Company Details

      • 11.11.2 Alacer Corp Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Alacer Corp Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.11.4 Alacer Corp Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Alfresa Pharma Corporation

      • 11.12.1 Alfresa Pharma Corporation Company Details

      • 11.12.2 Alfresa Pharma Corporation Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.12.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Bayer Healthcare AG

      • 11.13.1 Bayer Healthcare AG Company Details

      • 11.13.2 Bayer Healthcare AG Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Bayer Healthcare AG Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.13.4 Bayer Healthcare AG Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 AbbVie Inc

      • 11.14.1 AbbVie Inc Company Details

      • 11.14.2 AbbVie Inc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 AbbVie Inc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.14.4 AbbVie Inc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 AstraZeneca plc

      • 11.15.1 AstraZeneca plc Company Details

      • 11.15.2 AstraZeneca plc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 AstraZeneca plc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.15.4 AstraZeneca plc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Novartis International AG

      • 11.16.1 Novartis International AG Company Details

      • 11.16.2 Novartis International AG Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Novartis International AG Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.16.4 Novartis International AG Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Alkalon A/S

      • 11.17.1 Alkalon A/S Company Details

      • 11.17.2 Alkalon A/S Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Alkalon A/S Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.17.4 Alkalon A/S Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 The Colgate-Palmolive Company

      • 11.18.1 The Colgate-Palmolive Company Company Details

      • 11.18.2 The Colgate-Palmolive Company Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.18.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 Roche Holding AG

      • 11.19.1 Roche Holding AG Company Details

      • 11.19.2 Roche Holding AG Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 Roche Holding AG Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.19.4 Roche Holding AG Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    • 11.20 Merck & Co, Inc

      • 11.20.1 Merck & Co, Inc Company Details

      • 11.20.2 Merck & Co, Inc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.20.3 Merck & Co, Inc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

      • 11.20.4 Merck & Co, Inc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

      • 11.20.5 Recent Research and Development Strategies

    12 Global Over the Counter (OTC) Drugs and Dietary Supplements Market Outlook by Types and Applications to 2028

    • 12.1 Global Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global by Category Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Vitamin and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Cough & Cold Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Analgesics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Gastrointestinal Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Sleep Aids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Otic Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Wart Removers Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.9 Global Mouth Care Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.10 Global Ophthalmic Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.11 Global Other Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.12 Global by Dosage Form Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.13 Global Tablets Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.14 Global Hard Capsules Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.15 Global Powders Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.16 Global Ointments Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.17 Global Soft Capsules Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.18 Global Liquids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.19 Global Others Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.20 Global by Product Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.21 Global Branded Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.22 Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Grocery Stores Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Vitamin Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Health Food Stores Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Over the Counter (OTC) Drugs and Dietary Supplements Market Analysis and Outlook to 2028

    • 13.1 Global Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.2.2 Canada Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.2 UK Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.3 Spain Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.5 France Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.6 Italy Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.8 Finland Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.9 Norway Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.11 Poland Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.12 Russia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.2 Japan Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.3 India Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.3 Chile Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.6 Peru Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.6.3 Oman Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Over the Counter (OTC) Drugs and Dietary Supplements

    • Figure of Over the Counter (OTC) Drugs and Dietary Supplements Picture

    • Table Global Over the Counter (OTC) Drugs and Dietary Supplements Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Over the Counter (OTC) Drugs and Dietary Supplements Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global by Category Consumption and Growth Rate (2017-2022)

    • Figure Global Vitamin and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Global Cough & Cold Products Consumption and Growth Rate (2017-2022)

    • Figure Global Analgesics Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Products Consumption and Growth Rate (2017-2022)

    • Figure Global Sleep Aids Consumption and Growth Rate (2017-2022)

    • Figure Global Otic Products Consumption and Growth Rate (2017-2022)

    • Figure Global Wart Removers Consumption and Growth Rate (2017-2022)

    • Figure Global Mouth Care Products Consumption and Growth Rate (2017-2022)

    • Figure Global Ophthalmic Products Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global by Dosage Form Consumption and Growth Rate (2017-2022)

    • Figure Global Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global Hard Capsules Consumption and Growth Rate (2017-2022)

    • Figure Global Powders Consumption and Growth Rate (2017-2022)

    • Figure Global Ointments Consumption and Growth Rate (2017-2022)

    • Figure Global Soft Capsules Consumption and Growth Rate (2017-2022)

    • Figure Global Liquids Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global by Product Consumption and Growth Rate (2017-2022)

    • Figure Global Branded Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Grocery Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Vitamin Consumption and Growth Rate (2017-2022)

    • Figure Global Health Food Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Over the Counter (OTC) Drugs and Dietary Supplements Consumption by Country (2017-2022)

    • Table North America Over the Counter (OTC) Drugs and Dietary Supplements Consumption by Country (2017-2022)

    • Figure United States Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Canada Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Mexico Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table Europe Over the Counter (OTC) Drugs and Dietary Supplements Consumption by Country (2017-2022)

    • Figure Germany Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure UK Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Spain Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Belgium Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure France Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Italy Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Denmark Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Finland Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Norway Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Sweden Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Poland Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Russia Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Turkey Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table APAC Over the Counter (OTC) Drugs and Dietary Supplements Consumption by Country (2017-2022)

    • Figure China Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Japan Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure India Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure South Korea Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Thailand Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Singapore Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Philippines Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table South America Over the Counter (OTC) Drugs and Dietary Supplements Consumption by Country (2017-2022)

    • Figure Brazil Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Colombia Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Chile Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Argentina Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Peru Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table GCC Over the Counter (OTC) Drugs and Dietary Supplements Consumption by Country (2017-2022)

    • Figure Bahrain Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Oman Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Qatar Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table Africa Over the Counter (OTC) Drugs and Dietary Supplements Consumption by Country (2017-2022)

    • Figure Nigeria Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure South Africa Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Egypt Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Algeria Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table Oceania Over the Counter (OTC) Drugs and Dietary Supplements Consumption by Country (2017-2022)

    • Figure Australia Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Over the Counter (OTC) Drugs and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table Gilead Sciences Company Details

    • Table Gilead Sciences Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Gilead Sciences Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Johnson & Johnson Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table GlaxoSmithKline plc Company Details

    • Table GlaxoSmithKline plc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table GlaxoSmithKline plc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Pfizer Inc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Alcon Inc Company Details

    • Table Alcon Inc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alcon Inc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Alcon Inc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Sanofi SA Company Details

    • Table Sanofi SA Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Sanofi SA Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Reckitt Benckiser Plc Company Details

    • Table Reckitt Benckiser Plc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reckitt Benckiser Plc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Reckitt Benckiser Plc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Allergan, Plc Company Details

    • Table Allergan, Plc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan, Plc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Allergan, Plc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Alliance Healthcare Company Details

    • Table Alliance Healthcare Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alliance Healthcare Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Alliance Healthcare Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Bausch & Lomb Company Details

    • Table Bausch & Lomb Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch & Lomb Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Bausch & Lomb Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Alacer Corp Company Details

    • Table Alacer Corp Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alacer Corp Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Alacer Corp Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Alfresa Pharma Corporation Company Details

    • Table Alfresa Pharma Corporation Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alfresa Pharma Corporation Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Alfresa Pharma Corporation Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Bayer Healthcare AG Company Details

    • Table Bayer Healthcare AG Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare AG Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Bayer Healthcare AG Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table AbbVie Inc Company Details

    • Table AbbVie Inc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table AbbVie Inc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table AstraZeneca plc Company Details

    • Table AstraZeneca plc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca plc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table AstraZeneca plc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Novartis International AG Company Details

    • Table Novartis International AG Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International AG Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Novartis International AG Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Alkalon A/S Company Details

    • Table Alkalon A/S Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alkalon A/S Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Alkalon A/S Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table The Colgate-Palmolive Company Company Details

    • Table The Colgate-Palmolive Company Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table The Colgate-Palmolive Company Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table The Colgate-Palmolive Company Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Roche Holding AG Company Details

    • Table Roche Holding AG Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Holding AG Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Roche Holding AG Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Table Merck & Co, Inc Company Details

    • Table Merck & Co, Inc Over the Counter (OTC) Drugs and Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Over the Counter (OTC) Drugs and Dietary Supplements Main Business and Markets Served

    • Table Merck & Co, Inc Over the Counter (OTC) Drugs and Dietary Supplements Product Portfolio

    • Figure Global by Category Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vitamin and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cough & Cold Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Analgesics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sleep Aids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Otic Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Wart Removers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mouth Care Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ophthalmic Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global by Dosage Form Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hard Capsules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Powders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ointments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Soft Capsules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liquids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global by Product Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Branded Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Grocery Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vitamin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Health Food Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Table North America Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure United States Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure Germany Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure China Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure Brazil Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure Australia Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Over the Counter (OTC) Drugs and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.